Advisors Preferred’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-819
| Closed | -$45K | – | 181 |
|
2020
Q3 | $45K | Buy |
+819
| New | +$45K | 0.01% | 120 |
|
2017
Q2 | – | Sell |
-393
| Closed | -$20 | – | 234 |
|
2017
Q1 | $20 | Buy |
+393
| New | +$20 | 0.01% | 170 |
|
2016
Q1 | – | Sell |
-411
| Closed | -$22K | – | 230 |
|
2015
Q4 | $22K | Sell |
411
-420
| -51% | -$22.5K | 0.01% | 132 |
|
2015
Q3 | $41K | Sell |
831
-44,997
| -98% | -$2.22M | 0.04% | 77 |
|
2015
Q2 | $2.67M | Buy |
45,828
+40,656
| +786% | +$2.37M | 1.5% | 14 |
|
2015
Q1 | $297K | Buy |
5,172
+4,197
| +430% | +$241K | 0.16% | 70 |
|
2014
Q4 | $49.2K | Sell |
975
-3,024
| -76% | -$152K | 0.02% | 229 |
|
2014
Q3 | $187K | Sell |
3,999
-40,530
| -91% | -$1.9M | 0.12% | 75 |
|
2014
Q2 | $2.01M | Buy |
44,529
+38,946
| +698% | +$1.76M | 1.02% | 36 |
|
2014
Q1 | $236K | Buy |
5,583
+1,596
| +40% | +$67.4K | 0.11% | 135 |
|
2013
Q4 | $156K | Buy |
+3,987
| New | +$156K | 0.09% | 104 |
|